Indira Tendolkar has been appointed Professor of Clinical Neuroscience in Psychiatry at Radboud University / Radboud university medical center with effect from 1 October 2019.
Indira Tendolkar is an expert in the field of diagnostics and treatment methods in psychiatry and its border areas with other forms of medicine. She works at the interface between research and treatment and applies new research insights to diagnostics and patient treatment, particularly in the case of stress-related mental disorders. Since 2003 she has been affiliated with the Donders Institute for Brain, Cognition and Behaviour and in 2018 she became a member of the board.
Indira Tendolkar (1968, Duisburg) grew up in Germany and studied medicine at the University of Aachen. She received her doctorate (magna cum laude) in 1995 with a neurophysiological study of retinal changes in diabetic patients. She then specialised in neurology, psychiatry and psychotherapy and worked as a researcher and clinician at the universities of Zurich, Magdeburg, Cologne and St Andrews. In 2006 she obtained her habilitation at the University of Cologne with research into memory disorders in patients with schizophrenia.
Declarative memory systemIn her research Tendolkar focuses on the declarative memory system (a kind of long-term memory). She developed new experiments that test neutral and emotional forms of that memory with, among other things, brain scans and measurement of electrical activity of nerve cells.
She unravelled the neural basis of chronic and treatment-resistant depression and started a line of research in which she used MRI techniques to study chronic depression and the vulnerability of stress-related psychological disorders during the lifetime. She has set up a research line to identify the areas of the brain associated with affective disorders such as anxiety and depression. She uses this as a starting point for new experimental treatment techniques in which she specifically tries to change the underlying dysfunctional memory processes.
As a professor, she will bridge the gap between neuroscientific findings and clinical application with the aim of personalising clinical diagnosis and treatment.
Related news items
'Stofwisselkracht' grant for Paola de Haas and Alessandra Cambi5 December 2019
Paola de Haas and Alessandra Cambi, theme Nanomedicine, have recently been awarded a grant from ‘Stichting Stofwisselkracht’ for their project entitled “Identification of immune-related symptoms in Congenital Disorders of Glycosylation”.read more
Newly appointed Junior Principal Clinicians3 December 2019
The appointed junior Principal Clinician for RIMLS are Heidi Zweers-van Essen and Jenneke Leentjens. These caregivers are at the forefront of renewing patient care and take the lead in the development and realization of the Radboudumc vision.read more
Large research grant for Radboudumc Health Academy & HAN3 December 2019
The Radboudumc Health Academy and the HAN receive a large research grant of 875.000 euro from the NRO (Nationaal Regieorgaan voor Onderwijsonderzoek) on developing flexible expertise.read more
Exploration meeting Academic Alliance on Oncology2 December 2019
Within the Academic Alliance, the Maastricht UMC+ and Radboudumc are already working together in several areas. And this is happening in more and more fields. On 27 November researchers from both umc's met during the fourth Exploration meeting, this time with the theme: Oncology.read more
How a DNA virus evades small RNA-based immunity29 November 2019
Gijs Overheul, Pascal Miesen and Ronald van Rij, theme Infectious diseases and global health, have elucidated the mechanism by which a DNA virus evades small RNA-based immunity of the host. They have published their results in PNAS.read more